Phase one clinical trial is underway for the COVID-19 nasal vaccine produced by St. Louis startup.

Kathleen Berger and Dr. David Curiel, Professor of Radiation Oncology at Washington University, discuss Phase I clinical trials of the COVID-19 nasal spray vaccine.

Bibliographic Details

Other Authors:	Zigrang, Gary (Speaker), Curiel, David (academic.), Berger, Kathleen (Narrator)
Format:	Video
Language:	English
Language Notes:	Closed-captioned in English.
Published:	[Place of publication not identified] : Educate.Today, 2020.
Subjects:	Vaccines > Testing. Clinical trials. COVID-19 (Disease) > Vaccination. Clinical Trials as Topic Études cliniques. COVID-19 > Vaccination.
Online Access:	Connect to this streaming video